IRIS
CERULLO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.238
NA - Nord America 2.641
EU - Europa 2.107
SA - Sud America 387
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.517
SG - Singapore 1.340
RU - Federazione Russa 998
VN - Vietnam 646
CN - Cina 576
IT - Italia 438
BR - Brasile 304
HK - Hong Kong 266
FR - Francia 182
DE - Germania 116
IN - India 98
NL - Olanda 83
JP - Giappone 75
CA - Canada 65
GB - Regno Unito 65
FI - Finlandia 61
BD - Bangladesh 54
UA - Ucraina 36
MX - Messico 35
KR - Corea 33
SE - Svezia 33
AR - Argentina 28
ZA - Sudafrica 24
IE - Irlanda 22
CI - Costa d'Avorio 19
IQ - Iraq 19
PK - Pakistan 17
PL - Polonia 17
PH - Filippine 16
TH - Thailandia 15
AT - Austria 14
ES - Italia 14
EC - Ecuador 13
ID - Indonesia 11
CL - Cile 9
CO - Colombia 9
PY - Paraguay 9
TR - Turchia 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
JO - Giordania 6
MA - Marocco 6
TW - Taiwan 6
PE - Perù 5
TN - Tunisia 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BH - Bahrain 2
BZ - Belize 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SV - El Salvador 2
TJ - Tagikistan 2
AL - Albania 1
AU - Australia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
DM - Dominica 1
EU - Europa 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LV - Lettonia 1
MK - Macedonia 1
NA - Namibia 1
NE - Niger 1
Totale 8.446
Salva come PNG Salva come JPEG
Città #
Singapore 631
San Jose 405
Hong Kong 254
Moscow 240
Ashburn 211
Ho Chi Minh City 174
Chandler 162
Santa Clara 152
Beijing 151
Hanoi 142
Naples 131
Hefei 95
Los Angeles 81
Millbury 81
Lauterbourg 75
The Dalles 65
Amsterdam 62
Tokyo 61
New York 51
Boston 48
Napoli 42
Delhi 38
Princeton 38
Buffalo 35
Da Nang 34
Frankfurt am Main 34
Nanjing 34
Des Moines 32
Lawrence 30
Council Bluffs 28
Munich 28
Ottawa 27
Redondo Beach 27
Haiphong 26
Seattle 26
Dallas 24
Denver 24
Jacksonville 23
Rome 23
Wilmington 23
Helsinki 22
Brooklyn 21
Mexico City 20
Nanchang 20
São Paulo 19
Atlanta 17
Houston 17
Shanghai 17
Stockholm 16
Montreal 15
Orem 15
Phoenix 15
Seoul 15
Warsaw 14
Chennai 13
Chicago 13
Dong Ket 12
Johannesburg 12
Toronto 12
Turku 12
Kochi 11
Nuremberg 11
Shenyang 11
Hebei 10
Jiaxing 10
Milan 10
London 9
Dhaka 8
Manchester 8
Bexley 7
Biên Hòa 7
Can Tho 7
Lappeenranta 7
Poplar 7
Porto Alegre 7
Quận Bình Thạnh 7
San Francisco 7
Thái Bình 7
Tianjin 7
Acerra 6
Amman 6
Ankara 6
Baghdad 6
Bangkok 6
Belo Horizonte 6
Boardman 6
Hải Dương 6
Kronberg 6
Rio de Janeiro 6
Salvador 6
Tashkent 6
City of London 5
Curitiba 5
Karachi 5
Long Xuyen 5
Mumbai 5
Portici 5
Pune 5
Quito 5
Roubaix 5
Totale 4.460
Salva come PNG Salva come JPEG
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 237
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 181
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression. A Novel Role for the Endothelial Adrenergic System. 177
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 174
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 171
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy. 167
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 164
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/ double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumour activity 161
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 150
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice 144
AKT participates in endothelial dysfunction in hypertension. 141
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 136
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice 135
Oncolytic adenoviruses for cancer therapy 134
Solid phase synthesis of new dinuclear platinum complexes having a modified nucleoside as ligand. 133
Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex 133
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 131
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells 126
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 126
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer 121
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumor activity 117
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors 115
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. 114
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 113
The evolution of adenoviral vectors through genetic and chemical surface modifications 112
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 112
Discovery of a new PCC-mediated stereoselective oxidative spiroketalization process. An access to a new type of poly-THF spiroketal compound displaying anticancer activity 111
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile 110
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach 110
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 110
Generation of a helper-dependent adenoviral vector by homologous recombination 109
Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. 108
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 108
Artificially cloaked viral nanovaccine for cancer immunotherapy 108
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 107
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 107
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 107
Low-dose Decitabine enhances the efficacy of viral cancer vaccines for immunotherapy 106
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors 105
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors 104
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans 104
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 104
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 103
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 98
Uncovering the tumor antigen landscape: What to know about the discovery process 97
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 96
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 95
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors 94
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 91
Short-Term Correction of Arginase Deficiency in a Neonatal Murine Model with a Helper-Dependent Adenoviral Vector. 90
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 90
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy 89
PNA-functionalized adenoviral vectors as new tool for gene modulation in anti-cancer treatment 87
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors 85
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 85
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors. 84
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery 81
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 80
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to Helper-dependent adenovirus. 79
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus 72
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus 70
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver 69
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance 68
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus 68
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients 66
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 65
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 65
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids 64
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses 63
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment 61
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction 61
Design and application of oncolytic viruses for cancer immunotherapy 61
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus 60
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging 57
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo 57
GMCSF-armed vaccinia virus induces an antitumor immune response 55
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients 55
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus 55
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients 54
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy 54
Thiol-ene surface modifications for microchip electrophoresis based interaction assays 53
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 53
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform 51
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus 49
Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions 49
Pathogens: Our Allies against Cancer? 46
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response 11
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy 5
High-capacity adenoviral vector-mediated expression of an LDLR/transferrin chimeric protein in muscle reduces atherosclerosis in Ldlr−/− mice 3
Totale 8.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022348 6 0 0 7 1 11 3 12 48 11 78 171
2022/2023486 71 47 11 20 50 44 1 54 71 70 25 22
2023/2024407 31 76 52 19 15 36 19 58 3 4 61 33
2024/20252.320 135 122 10 15 66 122 247 147 143 280 845 188
2025/20264.518 469 321 449 418 765 189 415 252 627 317 128 168
2026/202719 19 0 0 0 0 0 0 0 0 0 0 0
Totale 8.587